SGI US Large Cap Equity I SILVX

Medalist Rating as of | See Summit Global Investment Hub
  • NAV / 1-Day Return 21.66  /  +0.05 %
  • Total Assets 231.8 Mil
  • Adj. Expense Ratio
    0.980%
  • Expense Ratio 0.980%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 0.77%
  • Turnover 88%

USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 10:17 PM GMT+0

Morningstar’s Analysis SILVX

Will SILVX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in SGI US Large Cap Equity I's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SILVX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 32.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

United Therapeutics Corp

3.86 8.2 Mil
Healthcare

Alphabet Inc Class A

3.68 7.8 Mil
Communication Services

Everest Group Ltd

3.48 7.4 Mil
Financial Services

Progressive Corp

3.36 7.1 Mil
Financial Services

Elevance Health Inc

3.30 7.0 Mil
Healthcare

Colgate-Palmolive Co

3.20 6.8 Mil
Consumer Defensive

Owens-Corning Inc

3.19 6.8 Mil
Industrials

Automatic Data Processing Inc

3.11 6.6 Mil
Technology

Meta Platforms Inc Class A

2.64 5.6 Mil
Communication Services

Cardinal Health Inc

2.60 5.5 Mil
Healthcare

Sponsor Center